Publications (101) Francisco Javier de Lucio Cazaña publications

filter_list

2024

  1. PGT como nueva diana farmacológica en la prevención de lesión renal aguda: estudio "in vitro"

    Dianas: revista de dianas terapéuticas, Vol. 13, Núm. 1

  2. Prostaglandin Transporter and Dipeptidyl Peptidase-4 as New Pharmacological Targets in the Prevention of Acute Kidney Injury in Diabetes: An In Vitro Study

    International Journal of Molecular Sciences, Vol. 25, Núm. 6

  3. Quantification of relevant metabolites in apoptotic bodies from HK-2 cells by targeted metabolomics based on liquid chromatography-tandem mass spectrometry

    Analytica Chimica Acta, Vol. 1329

  4. UHPLC-MS-based untargeted metabolomic strategy to reveal the metabolic differences between cisplatin first- and second-generation apoptotic bodies from HK-2 cells

    Microchemical Journal, Vol. 200

2023

  1. Exploring the Metabolic Differences between Cisplatin- and UV Light-Induced Apoptotic Bodies in HK-2 Cells by an Untargeted Metabolomics Approach

    International Journal of Molecular Sciences, Vol. 24, Núm. 8

  2. Prostaglandin transporter PGT as a new pharmacological target in the prevention of inflammatory cytokine-induced injury in renal proximal tubular HK-2 cells

    Life Sciences, Vol. 313

2021

  1. Comprehensive metabolomic study of the response of HK-2 cells to hyperglycemic hypoxic diabetic-like milieu

    Scientific Reports, Vol. 11, Núm. 1

  2. Exploratory metabolomic analysis based on reversed‐phase liquid chromatography–mass spectrometry to study an in vitro model of hypoxia‐induced metabolic alterations in hk‐2 cells

    International Journal of Molecular Sciences, Vol. 22, Núm. 14

  3. Intracellular prostaglandin E2 contributes to hypoxia-induced proximal tubular cell death

    Scientific Reports, Vol. 11, Núm. 1

  4. Mitochondria selective trackers for long-term imaging based on readily accessible neutral BODIPYs

    Chemical Communications, Vol. 57, Núm. 43, pp. 5318-5321

2020

  1. A non-targeted capillary electrophoresis-mass spectrometry strategy to study metabolic differences in an in vitro model of high-glucose induced changes in human proximal tubular HK-2 cells

    Molecules, Vol. 25, Núm. 3

  2. Author Correction: Mechanism and Consequences of The Impaired Hif-1α Response to Hypoxia in Human Proximal Tubular HK-2 Cells Exposed to High Glucose (Scientific Reports, (2019), 9, 1, (15868), 10.1038/s41598-019-52310-6)

    Scientific Reports

  3. El efecto antitumoral de DIDS en células de cáncer de próstata PC3: una nueva función para un viejo compuesto

    Dianas: revista de dianas terapéuticas, Vol. 9, Núm. 1

  4. Retinoic acid receptor-beta prevents cisplatin-induced proximal tubular cell death

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 7

  5. Time-series proteomic study of the response of HK-2 cells to hyperglycemic, hypoxic diabetic-like milieu

    PLoS ONE, Vol. 15, Núm. 6

  6. Uso de celecoxib vehiculado en nanopartículas de quitosano para el tratamiento del cáncer de próstata

    Dianas: revista de dianas terapéuticas, Vol. 9, Núm. 1

2019

  1. PROSTAGLANDIN E 2 stimulates cancer-related phenotypes in prostate cancer PC3 cells through cyclooxygenase-2

    Journal of Cellular Physiology, Vol. 234, Núm. 5, pp. 7548-7559

  2. An untargeted metabolomic strategy based on liquid chromatography-mass spectrometry to study high glucose-induced changes in HK-2 cells

    Journal of Chromatography A, Vol. 1596, pp. 124-133

  3. Apoptosis and cell proliferation in proximal tubular cells exposed to apoptotic bodies. Novel pathophysiological implications in cisplatin-induced renal injury

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1865, Núm. 9, pp. 2504-2515

  4. La prostaglandina E2 intracelular activa los fenotipos tumorales en cáncer de próstata de forma dependiente del factor inducible por hipoxia 1α

    Dianas: revista de dianas terapéuticas, Vol. 8, Núm. 1